Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

拉帕蒂尼 曲妥珠单抗 乳腺癌 医学 癌症研究 激酶 癌症 生长抑制 抗体 受体酪氨酸激酶 单克隆抗体 细胞生长 受体 肿瘤科 内科学 化学 免疫学 生物化学
作者
Maurizio Scaltriti,Federico Rojo,Alberto Ocaña,Judit Anido,Marta Guzmán,Javier Cortés,Serena Di Cosimo,Xavier Matías‐Guiu,Santiago Ramón y Cajal,Joaquín Arribas,Jose M Baselga
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:99 (8): 628-638 被引量:916
标识
DOI:10.1093/jnci/djk134
摘要

BACKGROUND: Women with HER2-overexpressing breast cancers have poor prognosis, and many are resistant to the HER2 monoclonal antibody trastuzumab. A subgroup of HER2-overexpressing tumors also express p95HER2, an amino terminally truncated receptor that has kinase activity. Because p95HER2 cannot bind to trastuzumab but should be responsive to the HER2 tyrosine kinase inhibitor lapatinib, we compared the sensitivity of tumors expressing p95HER2 and tumors expressing the full-length HER2 receptor to these agents. METHODS: MCF-7 and T47D breast cancer cells were stably transfected with either full-length HER2 or p95HER2. We studied the effects of trastuzumab and lapatinib on receptor signaling, cell proliferation, and the growth of xenograft tumors. A paraffin-based immunofluorescence assay was developed to study the association between p95HER2 expression and sensitivity to trastuzumab in patients with advanced breast cancer. All statistical tests were two-sided. RESULTS: Treatment of p95HER2-expressing cells with lapatinib inhibited p95HER2 phosphorylation, reduced downstream phosphorylation of Akt and mitogen-activated protein kinases, inhibited cell growth (MCF-7p95HER2 clones, lapatinib versus control, mean growth inhibition = 57.6% versus 22.6%, difference = 35%, 95% confidence interval [CI] = 22.5% to 47.3%; P<.001; T47Dp95HER2 clones, lapatinib versus control, mean growth inhibition = 36.8% versus 20%, difference = 16.8%, 95% CI = 11.3% to 22.3%, P<.001), and inhibited growth of MCF-7p95HER2 xenograft tumors (lapatinib versus control, mean = 288.8 versus 435 mm3, difference = 146.2 mm3, CI = 73.8 to 218.5 mm3, P = .002). By contrast, treatment with trastuzumab had no effect on any of these parameters. Of 46 patients with metastatic breast cancer who were treated with trastuzumab, only one of nine patients (11.1%) expressing p95HER2 responded to trastuzumab (with a partial response), whereas 19 of the 37 patients (51.4%) with tumors expressing full-length HER2 achieved either a complete (five patients) or a partial (14 patients) response (P = .029). CONCLUSIONS: Breast tumors that express p95HER2 are resistant to trastuzumab and may require alternative or additional anti-HER2-targeting strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
秋秋完成签到 ,获得积分10
3秒前
Clover04的应助被科研通管家采纳,获得10
3秒前
斯文败类的应助被科研通管家采纳,获得10
3秒前
NexusExplorer的应助被科研通管家采纳,获得10
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
共享精神的应助被科研通管家采纳,获得10
3秒前
4秒前
aajhajkahna的应助被科研通管家采纳,获得10
4秒前
传奇3的应助被科研通管家采纳,获得10
4秒前
田様的应助被科研通管家采纳,获得10
4秒前
Light完成签到,获得积分10
4秒前
乐乐笑语的应助被科研通管家采纳,获得10
4秒前
香蕉觅云的应助被科研通管家采纳,获得10
4秒前
DMSO完成签到 ,获得积分10
4秒前
Peiqi的应助被科研通管家采纳,获得30
4秒前
cdercder的应助被科研通管家采纳,获得10
4秒前
敏赵完成签到 ,获得积分10
5秒前
cdercder的应助被科研通管家采纳,获得10
5秒前
小二郎的应助被科研通管家采纳,获得10
5秒前
科研通AI65的应助被科研通管家采纳,获得10
5秒前
5秒前
领导范儿的应助被科研通管家采纳,获得10
5秒前
汉堡包的应助被科研通管家采纳,获得10
5秒前
YuJue的应助被科研通管家采纳,获得30
5秒前
小朱发布了新的文献求助10
6秒前
我是谁的应助被科研通管家采纳,获得20
6秒前
6秒前
cdercder的应助被科研通管家采纳,获得10
6秒前
6秒前
今天很美味完成签到 ,获得积分10
6秒前
LiYipeiiiiOvO完成签到 ,获得积分10
6秒前
科研通AI6.4的应助被令狐大侠采纳,获得30
6秒前
wangying完成签到,获得积分10
6秒前
秉朔完成签到,获得积分10
7秒前
老爱学习了完成签到,获得积分10
8秒前
憨子吧完成签到,获得积分10
9秒前
wangmeili完成签到,获得积分10
11秒前
13秒前
锦沫完成签到 ,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190389
求助须知:如何正确求助?哪些是违规求助? 9577501
关于积分的说明 21852916
捐赠科研通 7789263
什么是DOI,文献DOI怎么找? 3436376
关于科研通互助平台的介绍 2560204
邀请新用户注册赠送积分活动 2483032